Title: Development of an enzyme-linked immunosorbent assay for detection of cellular and in vivo LRRK2 S935 phosphorylation
Authors: Delbroek, Lore
Van Kolen, Kristof
Steegmans, Liesbeth
Cruz Carvalho da Cunha, Raquel
Mandemakers, Wim
Daneels, Guy
De Bock, Pieter-Jan
Zhang, Jinwei
Gevaert, Kris
De Strooper, Bart
Alessi, Dario R
Verstreken, Patrik
Moechars, Diederik W # ×
Issue Date: Mar-2013
Publisher: Pergamon Press
Series Title: Journal of Pharmaceutical and Biomedical Analysis vol:76 pages:49-58
Article number: 10.1016/j.jpba.2012.12.002
Abstract: After the discovery of kinase activating mutations in leucine-rich repeat kinase 2 (LRRK2) as associated with autosomal dominant forms of Parkinson's disease, inhibition of the kinase is being extensively explored as a disease modifying strategy. As signaling properties and substrate(s) of LRRK2 are poorly documented, autophosphorylation has been an important readout for the enzyme's activity. Western blotting using anti-phospho-S910 or S935 LRRK2 antibodies showed effectiveness in demonstrating inhibitory effects of compounds. In this communication we describe two types of enzyme-linked immunosorbent assays (ELISA) to determine LRRK2 protein levels and kinase activity. Both assays take advantage of the sensitivity of the earlier described total and pS935 antibodies for detection (Nichols et al., Biochem. J. 2010) [10]. The first assay is based on anti-GFP-based capturing of overexpressed LRRK2 and is highly suitable to show cellular effects of kinase inhibitors in a 96-well format. In the other platform anti-LRRK2-based capturing allows detection of endogenously expressed LRRK2 in rat tissue with no significant signal in tissue from LRRK2 knockout rats. Furthermore, both assays showed a significant reduction in pS935 levels on cellular and transgenic R1441C/G LRRK2. With the anti-LRRK2 ELISA we were able to detect LRRK2 phosphorylation in human peripheral blood mononuclear cells (PBMC). To conclude, we report two sensitive assays to monitor LRRK2 expression and kinase activity in samples coming from cellular and in vivo experimental settings. Both can show their value in drug screening and biomarker development but will also be useful in the elucidation of LRRK2-mediated signaling pathways.
ISSN: 0731-7085
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Department of Human Genetics - miscellaneous
Laboratory for the Research of Neurodegenerative Diseases
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Delbroek et al_2013.pdfMain article Published 1394KbAdobe PDFView/Open Request a copy
development+of+an+enzyme-linked+immunosorbent+assay+for+detection.pdfOA article Published 1453KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science